Our mission is to promote the coordinated delivery of several proven therapies that, when used in combination, have the capacity to improve the survival rate of victims who suffer out-of-hospital sudden cardiac arrest. Our goal is to increase the survival rate from its current 5 percent to more than 20 percent.